Network-1 Technologies, Inc. has released its financial results for the second quarter of 2025, reporting no revenue for the three months ended June 30, 2025, and revenue of $150,000 for the first half of the year, compared to $100,000 for the same period in 2024. The revenue in both years was generated from litigation settlements related to Network-1's Remote Power Patent. The company reported a net loss of $463,000 for the second quarter of 2025, an improvement from the net loss of $658,000 in the same quarter of 2024. For the first half of 2025, Network-1 reported a net loss of $826,000, compared to a net loss of $1.578 million for the same period in the previous year. These losses include Network-1's share of the net loss from its equity investee, ILiAD Biotechnologies, LLC, which amounted to $279,000 in the second quarter of 2025, down from $677,000 in the same quarter of 2024. As of June 30, 2025, Network-1 held cash, cash equivalents, and marketable securities totaling $38.485 million, and working capital of $38.288 million. The company believes it has sufficient resources to fund operations for the next twelve months and beyond. Network-1 is maintaining its semi-annual dividend policy, with cash dividends of $0.05 per share, amounting to $0.10 per share annually. Additionally, the company has extended and increased its share repurchase program, authorizing the repurchase of up to $5 million of common stock over the next 24 months. As of June 30, 2025, Network-1 has repurchased 10,525,705 shares at an aggregate cost of $20.185 million, with $4.995 million remaining under the repurchase program.